Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL64362 | 0.92 | ALDH1A1 (0.46) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL64281 | 0.92 | ALDH1A1 (0.46) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL21513122 | 0.90 | ALDH1A1 (0.45) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL9319516 | 0.88 | ALDH1A1 (0.50) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| Hydrochloric Acid SCHEMBL11582693 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL22261569 | 0.84 | ALDH1A1 (0.46) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL66021 | 0.83 | ALDH1A1 (0.54) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL9832786 | 0.82 | CA12 (0.48) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL3829435 | 0.82 | GAA (0.52) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 | |
| SCHEMBL2001291 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TRPA1CYP4F2CYP4A11CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362101-B2 | Multifunctional type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-01-29 | — | — | US | disclosed |
| US-8362101-B2 | Multifunctional type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-01-29 | — | — | US | disclosed |
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-24 | — | — | US | disclosed |
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-24 | — | — | US | disclosed |
| WO-2009147054-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2009-12-10 | — | — | WO | disclosed |
| EP-2130818-A1 | Multifunctional Type II photoinitiators and curable compositions | AGFA Graphics NV (BE) | 2009-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110069130-A1 | MULTIFUNCTIONAL TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | CRKL, CYTH2, CCNH | ALDH1A1 1579/4885TRPA1 3077/4885CYP4F2 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.